GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
V

Viatris VTRS · USD

Health Care · Pharmaceuticals · US listing · 🇺🇸 United States

S&P 500

Compare

20.49

+2.91%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$14.30bn

FY2016FY2025

Net income

−$3.51bn

FY2016FY2025

Free cash flow

$1.94bn

FY2016FY2025

Shareholders' equity

$14.71bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$14.30bn$14.74bn$15.43bn$16.26bn$17.89bn$11.95bn$11.50bn$11.43bn$11.91bn$11.08bn
Gross profit$5.01bn$5.62bn$6.44bn$6.50bn$5.58bn$3.80bn$3.90bn$4.00bn$4.78bn$4.70bn
Research and development$965.9m$808.7m$805.2m$662.2m$681.0m$512.6m$639.9m$704.5m$783.3m$826.8m
Operating income−$3.19bn$10.1m$766.2m$2.21bn−$28.2m−$223.4m$715.5m$905.6m$1.44bn$699.2m
Net income−$3.51bn−$634.2m$54.7m$2.08bn−$1.27bn−$669.9m$16.8m$352.5m$696.0m$480.0m
Diluted earnings per share-3.05-0.530.051.70-1.05-0.780.030.681.300.89

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$37.19bn$41.50bn$47.69bn$50.02bn$54.84bn$61.55bn$31.26bn$32.73bn$35.81bn$34.73bn
Cash and short-term investments$1.45bn$1.09bn$1.18bn$1.47bn$935.0m$1.05bn$584.7m$449.2m$418.9m$1.14bn
Total liabilities$22.48bn$22.87bn$27.22bn$28.95bn$34.35bn$38.60bn$19.37bn$20.57bn$22.50bn$23.61bn
Debt$14.52bn$14.05bn$18.13bn$19.27bn$23.07bn$25.79bn$12.67bn$13.82bn$14.72bn$15.54bn
Shareholders' equity$14.71bn$18.64bn$20.47bn$21.07bn$20.49bn$22.95bn$11.88bn$12.17bn$13.31bn$11.12bn
Shares outstanding1,153m1,193m1,200m1,221m1,209m854m517m517m536m537m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations$2.32bn$2.30bn$2.80bn$2.95bn$3.02bn$1.23bn$1.80bn$2.34bn$2.06bn$2.05bn
Capital spending−$378.8m−$326.0m−$474.5m−$443.0m−$509.4m−$681.2m−$406.0m−$252.1m−$275.9m−$390.4m
Free cash flow$1.94bn$1.98bn$2.33bn$2.51bn$2.51bn$550.6m$1.40bn$2.09bn$1.79bn$1.66bn
Dividends paid−$561.2m−$574.8m−$575.6m−$581.6m−$399.0m−$7.9m−$300,000−$399.0m——

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$3.76bn$3.52bn$3.70bn$3.76bn$3.58bn$3.25bn$3.53bn$3.75bn
Gross profit$1.46bn$1.16bn$1.13bn$1.38bn$1.33bn$1.16bn$1.22bn$1.46bn
Operating income$6.3m−$79.7m−$223.4m$251.6m$233.0m−$2.98bn−$406.3m$236.1m
Net income−$118.8m$176.4m−$340.1m−$128.2m−$4.6m−$3.04bn−$516.5m$94.8m
Diluted earnings per share-0.100.15-0.30-0.11-0.00-2.64-0.430.08
Cash from operations$381.0m$388.0m$815.0m$744.0m$219.0m$535.0m$482.0m$826.0m
Capital spending−$52.0m−$39.0m−$265.0m−$99.0m−$54.0m−$76.0m−$153.0m−$85.0m
Free cash flow$329.0m$349.0m$550.0m$645.0m$165.0m$459.0m$329.0m$741.0m
Total assets$35.04bn$36.83bn$37.19bn$37.92bn$38.41bn$38.47bn$41.50bn$44.75bn
Cash and short-term investments$886.5m$1.80bn$1.45bn$1.16bn$808.6m$1.00bn$1.09bn$2.05bn
Debt$13.35bn$14.34bn$14.52bn$14.54bn$14.58bn$14.28bn$14.13bn$15.83bn
Shareholders' equity$14.26bn$14.66bn$14.71bn$15.22bn$15.57bn$15.65bn$18.64bn$19.79bn

Financial ratios

Data as of 28 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin35.1%38.2%41.7%40.0%31.2%31.8%
Operating margin-22.3%0.1%5.0%13.6%-0.2%-1.9%
Net margin-24.6%-4.3%0.4%12.8%-7.1%-5.6%
Return on equity-23.9%-3.4%0.3%9.9%-6.2%-2.9%
Return on assets-9.5%-1.5%0.1%4.2%-2.3%-1.1%
Free cash flow yield13.1%12.4%15.3%15.6%16.4%12.6%
Revenue growth-3.0%-4.5%-5.1%-9.1%49.7%3.9%
Earnings growth454.2%-1259.4%-97.4%-263.8%89.4%-4087.5%
Current ratio1.30x1.65x1.67x1.58x1.10x1.22x
Debt to equity0.99x0.76x0.89x0.92x1.13x1.13x
Equity ratio39.6%44.9%42.9%42.1%37.4%37.3%
Interest coverage-6.78x0.02x1.34x3.73x-0.04x-0.45x
R&D as a share of sales6.8%5.5%5.2%4.1%3.8%4.3%
Buybacks as a share of market value3.4%0.6%1.7%-1.0%-41.5%-65.4%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-4.2%3.7%4.3%
Operating income—70.2%—
Net income—39.3%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin36.6%38.8%36.4%37.4%
Operating margin-11.0%-0.3%-0.5%3.3%
Net margin-14.3%-3.3%-4.4%-1.1%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-4.1-23.4237.66.5-12.9-23.9—40.132.642.6
Price to sales1.01.00.80.80.91.30.91.21.91.9

Market value over time

31 Oct 2016 to 25 Sept 2026, in USD

$19.13bn$20.74bn

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return-3%18%-5%-14%-27%-12%-28%-34%11%-30%

Dividends and splits

Per share, in the currency the company pays

Paid for 5 years. Last went ex-dividend on 21 Aug 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2007FY2006
Paid in the year0.360.480.480.480.480.330.120.24
  • 3-for-2 split · 9 Oct 2003
  • 3-for-2 split · 28 Jan 2003
  • 3-for-2 split · 16 Aug 1995
  • 2-for-1 split · 3 Aug 1992

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.